Reasons for Nicotine Pouch Use Among US Youth: 2025.

Authors

Yi-Chun Chang, Junhan Cho, Dayoung Bae, Alyssa F Harlow, Louisiana M Sanchez, Dae-Hee Han, Abbey R Masonbrink, Ming Li, Alina Agopian, Jessica L Barrington-Trimis, Richard A Miech, Leah R Meza, Adam M Leventhal

Published in

Pediatrics. Oct 26, 2026. Epub Oct 26, 2026.

Abstract

To document prevalence of reasons for nicotine pouch (NP) use and associations with use patterns among US youth.
Data were from US youth reporting ever NP use in the nationally representative 2025 Monitoring the Future survey. We estimated (1) prevalence of 10 reasons for NP use (yes/no) and (2) association of each reason with past 30-day NP use (yes/no) and frequency (1-30 days). For comparison, we contrasted reasons for NP and e-cigarette use among youth reporting NP use (n = 57) or e-cigarette use (n = 397) on at least 10 of the past 30 days.
Among 484 respondents reporting ever NP use (6.1% of youth surveyed on NP use and reasons), the most common reasons were experimentation (32.3%), nicotine buzz (30.5%), relaxation (22.7%), appealing flavors (17.4%), convenience (16.5%), socializing (16.0%), boredom (11.7%), and ability to conceal use (11.0%). To quit smoking (6.2%) and feeling addicted (2.1%) were less common. Flavors, convenience, and feeling addicted were positively associated with both past 30-day NP use (prevalence ratios [PRs] range = 1.50-2.35) and frequency (incidence rate ratios [IRRs] range = 1.60-2.55). Nicotine buzz, relaxation, socializing, concealment, and to quit smoking were only associated with past 30-day use (PRs range = 1.57-1.85). Experimentation was inversely associated with frequency (IRR = 0.42). The prevalence of reasons overlapped between NPs and e-cigarettes, with relaxation, convenience, nicotine buzz, and flavors most prevalent among youth regularly using each product.
Prevention and regulatory strategies addressing NP use reasons, particularly flavors and convenience, are warranted. Existing effective strategies targeting youth nicotine vaping may be applicable to NP use.

PMID:
42927773
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.